REFERENCES
- Berchtold, N. C., and Cotman, C. W. 1998. Evolution in the conceptualization of dementia and Alzheimer’s disease: Greco-Roman period to the 1960s. J. Neurobiol. Aging 19: 173–189.
- Bieschke, J., Zhang, Q., and Evan, T. 2005. Oxidative metabolites accelerate Alzheimer’s amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation. J. Biochem. 44: 4977–4983.
- Campos, A. C. E., and Molognoni, F. 2007. Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation. J. Neoplasia 9: 1111–1121.
- Huang, X., and Ren, K. 2010. Study progress on lignanoid in schisandra. J. Jilin Med. College 31: 46–49.
- Noelker, C., Schwake, M., and Balzer-Geldsetzer, M. 2012. Differentially expressed gene profile in the 6-hydroxy-dopamine-induced cell culture model of Parkinson’s disease. J. Neurosci Lett. 507: 10–15.
- Piaceri, I., Raspanti, B., and Tedde, A. 2015. Epigenetic modifications in Alzheimer’s disease: Cause or effect? J. Alzheimer’s Dis. 43: 1169–1173.
- Selkoe, D. J. 1994. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer’s disease. Annu. Rev. Cell Biol. 10: 373–403.
- Song, J. X., Lin, X., and Wong, R. N. 2011.Protective effects of dibenzocyclooctadiene lignans from Schisandra chinensis against beta-amyloid and homocysteine neurotoxicity in PC12 cells. Phytother. Res. 25:435–443.
- Valinluck, V., Tsai, H., and Rogstad, D. K. 2004. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein2 (MeCP2). J. Nucleic Acids Res. 32:4100–4108.
- Xiao, F., Weng, W., and Luo, H. 2010. Protection and therapeutic effect of the PC12 cells induced by beta amyloid damage by the alcohol. J. Traditional Chin. Med. Mater. 33:397–401.
- Yu, F., Tuo X., and Lu, J. 2007. Schisandrone improves learning and memory abilities of Alzheimer-like rats and influences expression of NF-κB, iNOS in rat hippocampus. J. Acad. Sec. Mil. Med. Univ. 28: 1351–1355.